{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:50:50Z","timestamp":1795020650430,"version":"4.10.1"},"reference-count":142,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T00:00:00Z","timestamp":1693958400000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.heliyon.2023.e19925","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T06:11:46Z","timestamp":1694758306000},"page":"e19925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Phage based vaccine: A novel strategy in prevention and treatment"],"prefix":"10.1016","volume":"9","author":[{"given":"Sharareh","family":"Mohammad Hasani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Ghafouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Kouhpayeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forouzan","family":"Amerizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilnaz","family":"Rahimmanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohre","family":"Amirkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Khanahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e19925_bib1","series-title":"Baylor University Medical Center Proceedings","article-title":"Edward Jenner and the history of smallpox and vaccination","author":"Riedel","year":"2005"},{"key":"10.1016\/j.heliyon.2023.e19925_bib2","series-title":"J Enner, E Dward (1749\u20131823)","author":"Baxby","year":"2005"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e19925_bib3","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3390\/vaccines8030504","article-title":"Bacteriophage-Based vaccines: a potent approach for antigen delivery","volume":"8","author":"Gonz\u00e1lez-Mora","year":"2020","journal-title":"Vaccines"},{"issue":"1645","key":"10.1016\/j.heliyon.2023.e19925_bib4","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0433","article-title":"The contribution of vaccination to global health: past, present and future","volume":"369","author":"Greenwood","year":"2014","journal-title":"Phil. Trans. Biol. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.biori.2017.10.001","article-title":"The development of veterinary vaccines: a review of traditional methods and modern biotechnology approaches","volume":"1","author":"Jorge","year":"2017","journal-title":"Biotechnology Research and Innovation"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib6","doi-asserted-by":"crossref","first-page":"a012518","DOI":"10.1101\/cshperspect.a012518","article-title":"Therapeutic and prophylactic applications of bacteriophage components in modern medicine","volume":"4","author":"Adhya","year":"2014","journal-title":"Cold Spring Harbor perspectives in medicine"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jviromet.2012.03.032","article-title":"Infective and inactivated filamentous phage as carriers for immunogenic peptides","volume":"183","author":"Samoylova","year":"2012","journal-title":"J. Virol Methods"},{"key":"10.1016\/j.heliyon.2023.e19925_bib8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3389\/fmicb.2015.00755","article-title":"Beyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold","volume":"6","author":"Henry","year":"2015","journal-title":"Front. Microbiol."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e19925_bib9","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1007\/s00253-014-5521-1","article-title":"Bacteriophage lambda display systems: developments and applications","volume":"98","author":"Nicastro","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"41","key":"10.1016\/j.heliyon.2023.e19925_bib10","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.1016\/j.vaccine.2010.07.047","article-title":"Dual expression system for assembling phage lambda display particle (LDP) vaccine to porcine Circovirus 2 (PCV2)","volume":"28","author":"Hayes","year":"2010","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e19925_bib11","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1128\/AAC.49.7.2874-2878.2005","article-title":"Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy","volume":"49","author":"Bruttin","year":"2005","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"15","key":"10.1016\/j.heliyon.2023.e19925_bib12","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1158\/0008-5472.CAN-05-4441","article-title":"Selection of tumor-binding ligands in cancer patients with phage display libraries","volume":"66","author":"Krag","year":"2006","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e19925_bib13","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1002\/jctb.5359","article-title":"Recovery and primary purification of bacteriophage M13 using aqueous two\u2010phase systems","volume":"92","author":"Gonz\u00e1lez\u2010Mora","year":"2017","journal-title":"J. Chem. Technol. Biotechnol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-9-9","article-title":"Bacteriophages and their implications on future biotechnology: a review","volume":"9","author":"Haq","year":"2012","journal-title":"Virol. J."},{"issue":"23","key":"10.1016\/j.heliyon.2023.e19925_bib15","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.vaccine.2008.03.042","article-title":"Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis","volume":"26","author":"Morales","year":"2008","journal-title":"Vaccine"},{"issue":"28","key":"10.1016\/j.heliyon.2023.e19925_bib16","doi-asserted-by":"crossref","first-page":"10416","DOI":"10.1073\/pnas.0403795101","article-title":"Treating cocaine addiction with viruses","volume":"101","author":"Carrera","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11\u201312","key":"10.1016\/j.heliyon.2023.e19925_bib17","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0264-410X(02)00609-6","article-title":"Reduction of \u03b2-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunization","volume":"21","author":"Frenkel","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e19925_bib18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/08923973.2015.1027917","article-title":"Cancer immunotherapy by a recombinant phage vaccine displaying EGFR mimotope: an in vivo study","volume":"37","author":"Asadi-Ghalehni","year":"2015","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e19925_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077238","article-title":"Protective immunity against Trichinella spiralis infection induced by a multi-epitope vaccine in a murine model","volume":"8","author":"Gu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2023.e19925_bib20","series-title":"Rna Bacteriophages","author":"Peabody","year":"2013"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e19925_bib21","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.apjtb.2017.06.001","article-title":"An overview on application of phage display technique in immunological studies","volume":"7","author":"Rami","year":"2017","journal-title":"Asian Pac. J. Trop. Biomed."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e19925_bib22","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.3390\/ijms13045179","article-title":"Filamentous bacteriophage fd as an antigen delivery system in vaccination","volume":"13","author":"Prisco","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e19925_bib23","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.vaccine.2009.12.059","article-title":"Engineering filamentous phage carriers to improve focusing of antibody responses against peptides","volume":"28","author":"van Houten","year":"2010","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e19925_bib24","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0965-1748(02)00095-4","article-title":"Plasmodium\u2013mosquito interactions, phage display libraries and transgenic mosquitoes impaired for malaria transmission","volume":"32","author":"Ghosh","year":"2002","journal-title":"Insect Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/viro.2000.0185","article-title":"Immunisation with phage displaying peptides representing single epitopes of the glycoprotein G can give rise to partial protective immunity to HSV-2","volume":"269","author":"Grabowska","year":"2000","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e19925_bib26","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.vaccine.2011.12.070","article-title":"Peptide vaccination is superior to genetic vaccination using a recombineered bacteriophage \u03bb subunit vaccine","volume":"30","author":"Thomas","year":"2012","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e19925_bib27","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1021\/bc300130z","article-title":"M13 bacteriophage display framework that allows sortase-mediated modification of surface-accessible phage proteins","volume":"23","author":"Hess","year":"2012","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.heliyon.2023.e19925_bib28","series-title":"Triple Tandem Mimotope Peptide of Epidermal Growth Factor Receptor Displaying on the Surface of M13 Phage Induces Anti-tumor Response in Mice Tumor Model","author":"Javanmardi","year":"2014"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e19925_bib29","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.biotechadv.2010.07.004","article-title":"Phage display: concept, innovations, applications and future","volume":"28","author":"Pande","year":"2010","journal-title":"Biotechnol. Adv."},{"issue":"23\u201324","key":"10.1016\/j.heliyon.2023.e19925_bib30","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.drudis.2013.09.001","article-title":"Phage display as a technology delivering on the promise of peptide drug discovery","volume":"18","author":"Hamzeh-Mivehroud","year":"2013","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e19925_bib31","first-page":"384","volume":"362","author":"Comeau","year":"2007","journal-title":"Modular architecture of the T4 phage superfamily: a conserved core genome and a plastic periphery"},{"issue":"34","key":"10.1016\/j.heliyon.2023.e19925_bib32","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1016\/j.vaccine.2011.03.051","article-title":"Inhibition of tumor angiogenesis in lung cancer by T4 phage surface displaying mVEGFR2 vaccine","volume":"29","author":"Ren","year":"2011","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.heliyon.2023.e19925_bib33","doi-asserted-by":"crossref","first-page":"12551","DOI":"10.1128\/JVI.02043-14","article-title":"Immunogenicity studies of proteins forming the T4 phage head surface","volume":"88","author":"D\u0105browska","year":"2014","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e19925_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01926-18","article-title":"A bacteriophage T4 nanoparticle-based dual vaccine against anthrax and plague","volume":"9","author":"Tao","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.heliyon.2023.e19925_bib35","series-title":"Immunization with M2e-Displaying T7 Bacteriophage Nanoparticles Protects against Influenza A Virus Challenge","author":"Hashemi","year":"2012"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e19925_bib36","first-page":"127","volume":"1","author":"Sipley","year":"1991","journal-title":"Analysis of bacteriophage T7 gene 10A and frameshifted 10B proteins"},{"issue":"21","key":"10.1016\/j.heliyon.2023.e19925_bib37","first-page":"6998","volume":"173","author":"Condron","year":"1991","journal-title":"Frameshifting in gene 10 of bacteriophage T7"},{"key":"10.1016\/j.heliyon.2023.e19925_bib38","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.vetmic.2017.04.023","article-title":"Immunogenicity of T7 bacteriophage nanoparticles displaying GH loop of foot-and-mouth disease virus (FMDV)","volume":"205","author":"Xu","year":"2017","journal-title":"Vet. Microbiol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib39","first-page":"714","article-title":"Advances in the T7 phage display system","volume":"17","author":"Deng","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e19925_bib40","first-page":"12","volume":"12","author":"Tolmachov","year":"2009","journal-title":"Can painting human cells with exogenous maltoporin enable efficient therapeutic gene transfer by bacteriophage lambda vectors?"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-0556-8-3","article-title":"Recombinant \u03bb-phage nanobioparticles for tumor therapy in mice models","volume":"8","author":"Ghaemi","year":"2010","journal-title":"Genet. Vaccine Ther."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e19925_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2017.e00407","article-title":"Lambda phage-based vaccine induces antitumor immunity in hepatocellular carcinoma","volume":"3","author":"Iwagami","year":"2017","journal-title":"Heliyon"},{"issue":"11","key":"10.1016\/j.heliyon.2023.e19925_bib43","first-page":"6025","volume":"96","author":"Gao","year":"1999","journal-title":"Making artificial antibodies: a format for phage display of combinatorial heterodimeric arrays"},{"issue":"20","key":"10.1016\/j.heliyon.2023.e19925_bib44","first-page":"12612","volume":"99","author":"Gao","year":"2002","journal-title":"A method for the generation of combinatorial antibody libraries using pIX phage display"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e19925_bib45","first-page":"599","volume":"7","author":"Rami","year":"2017","journal-title":"An overview on application of phage display technique in immunological studies"},{"key":"10.1016\/j.heliyon.2023.e19925_bib46","series-title":"Filamentous Bacteriophages: Biology and Applications","author":"Rakonjac","year":"2012"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e19925_bib47","first-page":"577","volume":"56","author":"Chauthaiwale","year":"1992","journal-title":"Bacteriophage lambda as a cloning vector"},{"key":"10.1016\/j.heliyon.2023.e19925_bib48","series-title":"Handbook of Systems Biology","first-page":"287","article-title":"Phenotypes and design principles in system design space","author":"Savageau","year":"2013"},{"key":"10.1016\/j.heliyon.2023.e19925_bib49","series-title":"Molecular Cloning: a Laboratory Manual","author":"Sambrook","year":"1989"},{"key":"10.1016\/j.heliyon.2023.e19925_bib50","volume":"vol. 4","author":"Johnson","year":"2002"},{"key":"10.1016\/j.heliyon.2023.e19925_bib51","series-title":"A Genetic Switch. Phage L and Higher Organisms","author":"Ptashne","year":"1992"},{"key":"10.1016\/j.heliyon.2023.e19925_bib52","series-title":"Molecular Genetics of Bacteria","author":"Dale","year":"2004"},{"key":"10.1016\/j.heliyon.2023.e19925_bib53","series-title":"Molecular Biology of Bacteriophage T4","author":"Karam","year":"1994"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e19925_bib54","first-page":"1968","volume":"237","author":"Josse","year":"1962","journal-title":"Glucosylation of deoxyribonucleic acid: III. \u03b1-AND \u03b2-glucosyl transferases from T4-infected escherichia coli"},{"key":"10.1016\/j.heliyon.2023.e19925_bib55","first-page":"108","volume":"vol. 68","author":"Pratt","year":"1963"},{"key":"10.1016\/j.heliyon.2023.e19925_bib56","series-title":"DNA Replication","author":"Kornberg","year":"1992"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib57","first-page":"137","volume":"34","author":"Warren","year":"1980","journal-title":"Modified bases in bacteriophage DNAs"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib58","first-page":"56","volume":"42","author":"Loenen","year":"2014","journal-title":"The other face of restriction: modification-dependent enzymes"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e19925_bib59","first-page":"1129","volume":"75","author":"Gommers-Ampt","year":"1993","journal-title":"\u03b2-D-glucosyl-hydroxymethyluracil: a novel modified base present in the DNA of the parasitic protozoan T. brucei"},{"issue":"5929","key":"10.1016\/j.heliyon.2023.e19925_bib60","first-page":"929","volume":"324","author":"Kriaucionis","year":"2009","journal-title":"The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e19925_bib61","volume":"13","author":"Zhu","year":"2022","journal-title":"A bacteriophage-based, highly efficacious, needle-and adjuvant-free, mucosal COVID-19 vaccine"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e19925_bib62","first-page":"436","volume":"11","author":"Palma","year":"2023","journal-title":"Aspects of Phage-Based Vaccines for Protein and Epitope Immunization"},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2023.e19925_bib63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vetimm.2003.12.009","article-title":"Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis","volume":"99","author":"Manoutcharian","year":"2004","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.heliyon.2023.e19925_bib64","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2019.01.003","article-title":"Bacteriophage interactions with mammalian tissue: therapeutic applications","volume":"145","author":"Huh","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e19925_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003903","article-title":"An epitope-substituted DNA vaccine improves safety and immunogenicity against dengue virus type 2","volume":"9","author":"Tang","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"20\u201322","key":"10.1016\/j.heliyon.2023.e19925_bib79","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1016\/S0264-410X(00)00561-2","article-title":"Induction of hepatitis B virus-specific cytotoxic T lymphocytes response in vivo by filamentous phage display vaccine","volume":"19","author":"Wan","year":"2001","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e19925_bib80","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.4049\/jimmunol.180.6.3719","article-title":"The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2-restricted peptides and to induce strong antitumor CTL responses","volume":"180","author":"Sartorius","year":"2008","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib81","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jviromet.2006.09.017","article-title":"Bacteriophage T4 nanoparticle capsid surface SOC and HOC bipartite display with enhanced classical swine fever virus immunogenicity: a powerful immunological approach","volume":"139","author":"Wu","year":"2007","journal-title":"J. Virol Methods"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e19925_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003495","article-title":"Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccines","volume":"9","author":"Tao","year":"2013","journal-title":"PLoS Pathog."},{"issue":"40","key":"10.1016\/j.heliyon.2023.e19925_bib83","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1016\/j.vaccine.2005.05.024","article-title":"The potential of phage display virions expressing malignant tumor specific antigen MAGE-A1 epitope in murine model","volume":"23","author":"Fang","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib72","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1006\/viro.1997.8632","article-title":"Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus","volume":"234","author":"Bastien","year":"1997","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e19925_bib68","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10330-006-0474-1","article-title":"Immunotherapy of EGFR-positive tumor based on recombinant EGFR phage vaccine","volume":"5","author":"Liu","year":"2006","journal-title":"Chin. Ger. J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e19925_bib73","first-page":"455","article-title":"Displaying of GnRH peptides on bacteriophage T7 and its immunogenicity in mice model","volume":"11","author":"Xu","year":"2017","journal-title":"International Journal of Bioengineering and Life Sciences"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e19925_bib84","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/aps.2009.44","article-title":"Antitumor activity of endogenous mFlt4 displayed on a T4 phage nanoparticle surface","volume":"30","author":"Ren","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib66","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.virol.2005.10.037","article-title":"In vitro binding of anthrax protective antigen on bacteriophage T4 capsid surface through Hoc\u2013capsid interactions: a strategy for efficient display of large full-length proteins","volume":"345","author":"Shivachandra","year":"2006","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e19925_bib67","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.4161\/hv.21703","article-title":"Phage display\u2014a powerful technique for immunotherapy: 1. Introduction and potential of therapeutic applications","volume":"8","author":"Bazan","year":"2012","journal-title":"Hum. Vaccines Immunother."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e19925_bib69","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/aps.2009.44","article-title":"Antitumor activity of endogenous mFlt4 displayed on a T4 phage nanoparticle surface","volume":"30","author":"Ren","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e19925_bib70","first-page":"3991","volume":"24","author":"Dabrowska","year":"2004","journal-title":"Anticancer activity of bacteriophage T4 and its mutant HAP1 in mouse experimental tumour models"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e19925_bib71","first-page":"3105","volume":"182","author":"Eriksson","year":"2009","journal-title":"Tumor-specific bacteriophages induce tumor destruction through activation of tumor-associated macrophages"},{"key":"10.1016\/j.heliyon.2023.e19925_bib74","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.toxicon.2016.11.247","article-title":"Identification of the immunogenic epitopes of the whole venom component of the Hemiscorpius lepturus scorpion using the phage display peptide library","volume":"124","author":"Jahdasani","year":"2016","journal-title":"Toxicon"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e19925_bib75","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1517\/14712590902870386","article-title":"Mimotope vaccination\u2013from allergy to cancer","volume":"9","author":"Knittelfelder","year":"2009","journal-title":"Expet Opin. Biol. Ther."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e19925_bib76","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1128\/IAI.69.10.6511-6514.2001","article-title":"Epitope mapping of neutralizing botulinum neurotoxin A antibodies by phage display","volume":"69","author":"Mullaney","year":"2001","journal-title":"Infect. Immun."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e19925_bib85","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.4314\/tjpr.v14i7.5","article-title":"Identification of immunotopes against Mycobacterium leprae as immune targets using PhDTm-12mer phage display peptide library","volume":"14","author":"Ferdosian","year":"2015","journal-title":"Trop. J. Pharmaceut. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12896-015-0167-3","article-title":"Application of M13 phage display for identifying immunogenic proteins from tick (Ixodes scapularis) saliva","volume":"15","author":"Becker","year":"2015","journal-title":"BMC Biotechnol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-015-0747-z","article-title":"Use of Phage Display technology in development of canine visceral leishmaniasis vaccine using synthetic peptide trapped in sphingomyelin\/cholesterol liposomes","volume":"8","author":"Toledo-Machado","year":"2015","journal-title":"Parasites Vectors"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6750-12-29","article-title":"Identification of immunogenic proteins and generation of antibodies against Salmonella Typhimurium using phage display","volume":"12","author":"Meyer","year":"2012","journal-title":"BMC Biotechnol."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e19925_bib77","first-page":"677","volume":"54","author":"Riemer","year":"2005","journal-title":"High-molecular-weight melanoma-associated antigen mimotope immunizations induce antibodies recognizing melanoma cells"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e19925_bib78","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4161\/bact.1.2.14590","article-title":"Pros and cons of phage therapy","volume":"1","author":"Loc-Carrillo","year":"2011","journal-title":"Bacteriophage"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e19925_bib89","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1574-695X.2010.00763.x","article-title":"Comparison of a bacteriophage-delivered DNA vaccine and a commercially available recombinant protein vaccine against hepatitis B","volume":"61","author":"Clark","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e19925_bib90","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jviromet.2009.11.008","article-title":"Evaluation of humoral and cellular immune responses against HSV-1 using genetic immunization by filamentous phage particles: a comparative approach to conventional DNA vaccine","volume":"163","author":"Hashemi","year":"2010","journal-title":"J. Virol Methods"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e19925_bib91","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/1389201013378671","article-title":"Phage displayed biomolecules as preventive and therapeutic agents","volume":"2","author":"Manoutcharian","year":"2001","journal-title":"Curr. Pharmaceut. Biotechnol."},{"issue":"13\u201314","key":"10.1016\/j.heliyon.2023.e19925_bib92","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.vaccine.2003.10.047","article-title":"Genetic immunisation against hepatitis B using whole bacteriophage \u03bb particles","volume":"22","author":"March","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.heliyon.2023.e19925_bib93","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.addr.2018.12.013","article-title":"Phage-based vaccines","volume":"145","author":"Bao","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.heliyon.2023.e19925_bib94","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/B978-0-12-394438-2.00002-5","article-title":"Phage as a modulator of immune responses: practical implications for phage therapy","volume":"83","author":"G\u00f3rski","year":"2012","journal-title":"Adv. Virus Res."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e19925_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8050650","article-title":"Recombinant filamentous bacteriophages Encapsulated in Biodegradable polymeric microparticles for stimulation of innate and adaptive immune responses","volume":"8","author":"Jamaledin","year":"2020","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib96","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bbrc.2010.09.094","article-title":"Immunological basis of M13 phage vaccine: regulation under MyD88 and TLR9 signaling","volume":"402","author":"Hashiguchi","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e19925_bib97","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00430-006-0011-4","article-title":"Effects of bacteriophages on free radical production and phagocytic functions","volume":"195","author":"Przerwa","year":"2006","journal-title":"Med. Microbiol. Immunol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e19925_bib98","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1574-695X.2002.tb00614.x","article-title":"Effect of phage therapy on the turnover and function of peripheral neutrophils","volume":"34","author":"Weber-Dabrowska","year":"2002","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"21","key":"10.1016\/j.heliyon.2023.e19925_bib99","doi-asserted-by":"crossref","first-page":"12551","DOI":"10.1128\/JVI.02043-14","article-title":"Immunogenicity studies of proteins forming the T4 phage head surface","volume":"88","author":"D\u0105browska","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.heliyon.2023.e19925_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.856542","article-title":"Editorial: pharmacological and immunological action of bacteriophages: focus on phage therapy","volume":"13","author":"Gangwar","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib101","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10142","article-title":"Phage display as a tool for vaccine and immunotherapy development","volume":"5","author":"Hess","year":"2020","journal-title":"Bioeng Transl Med"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e19925_bib102","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1084\/jem.20090199","article-title":"Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy","volume":"206","author":"Schmitz","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.heliyon.2023.e19925_bib103","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2217\/fmb-2017-0049","article-title":"Phages and immunomodulation","volume":"12","author":"G\u00f3rski","year":"2017","journal-title":"Future Microbiol."},{"key":"10.1016\/j.heliyon.2023.e19925_bib104","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.copbio.2020.11.002","article-title":"Phages in vaccine design and immunity; mechanisms and mysteries","volume":"68","author":"de Vries","year":"2021","journal-title":"Curr. Opin. Biotechnol."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e19925_bib105","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.4049\/jimmunol.1701745","article-title":"Contribution of the immune response to phage therapy","volume":"200","author":"Krut","year":"2018","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e19925_bib106","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0264-410X(97)00072-8","article-title":"Immunogenicity of filamentous phage displaying peptide mimotopes after oral administration","volume":"15","author":"Delmastro","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.heliyon.2023.e19925_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.615445","article-title":"Study on the effect of oral administration of bacteriophages in charles foster rats with special reference to immunological and adverse effects","volume":"12","author":"Gangwar","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e19925_bib108","series-title":"Design and Proof-Of-Concept for Targeted Phage-Based COVID-19 Vaccination Strategies with a Streamlined Cold-free Supply Chain","author":"Staquicini","year":"2021"},{"issue":"18","key":"10.1016\/j.heliyon.2023.e19925_bib109","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.7314\/APJCP.2015.16.18.8019","article-title":"Phage particles as vaccine delivery vehicles: concepts, applications and prospects","volume":"16","author":"Jafari","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e19925_bib110","first-page":"536","volume":"10","author":"Rao","year":"2003","journal-title":"Expression of a 28-kilodalton glutathione S-transferase antigen of Schistosoma mansoni on the surface of filamentous phages and evaluation of its vaccine potential"},{"key":"10.1016\/j.heliyon.2023.e19925_bib111","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3389\/fimmu.2018.01173","article-title":"Vaccination with recombinant filamentous fd phages against parasite infection requires TLR9 expression","volume":"9","author":"Gomes-Neto","year":"2018","journal-title":"Front. Immunol."},{"issue":"20\u201322","key":"10.1016\/j.heliyon.2023.e19925_bib128","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1016\/S0264-410X(00)00561-2","article-title":"Induction of hepatitis B virus-specific cytotoxic T lymphocytes response in vivo by filamentous phage display vaccine","volume":"19","author":"Wan","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.heliyon.2023.e19925_bib119","series-title":"A Meta-Analysis and Experiment Assessing Phage-Based FMDV Vaccine","first-page":"2020","author":"Wu","year":"2020"},{"issue":"15","key":"10.1016\/j.heliyon.2023.e19925_bib115","doi-asserted-by":"crossref","first-page":"7688","DOI":"10.1128\/JVI.00235-06","article-title":"Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines","volume":"80","author":"Sathaliyawala","year":"2006","journal-title":"J. Virol."},{"issue":"47","key":"10.1016\/j.heliyon.2023.e19925_bib118","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1016\/j.vaccine.2009.08.019","article-title":"Immunogenicity of bacteriophage lambda particles displaying porcine Circovirus 2 (PCV2) capsid protein epitopes","volume":"27","author":"Gamage","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e19925_bib117","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jviromet.2009.11.008","article-title":"Evaluation of humoral and cellular immune responses against HSV-1 using genetic immunization by filamentous phage particles: a comparative approach to conventional DNA vaccine","volume":"163","author":"Hashemi","year":"2010","journal-title":"J Virol Methods"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib120","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1006\/viro.1997.8632","article-title":"Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus","volume":"234","author":"Bastien","year":"1997","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e19925_bib123","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01926-18","article-title":"A bacteriophage T4 nanoparticle-based dual vaccine against anthrax and plague","volume":"9","author":"Tao","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.heliyon.2023.e19925_bib127","article-title":"Recombinant phage elicits protective immune response against systemic S. Globosa infection in mouse model","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e19925_bib126","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4161\/hv.27714","article-title":"Hybrid phage displaying SLAQVKYTSASSI induces protection against Candida albicans challenge in BALB\/c mice","volume":"10","author":"Wang","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.heliyon.2023.e19925_bib129","unstructured":"Hai Xu, Y.W., Xi Bao, Bihua Deng, Pengcheng Li, Yu Lu, Displaying of GnRH Peptides on Bacteriophage T7 and its Immunogenicity in Mice Model.."},{"issue":"28","key":"10.1016\/j.heliyon.2023.e19925_bib130","doi-asserted-by":"crossref","first-page":"10416","DOI":"10.1073\/pnas.0403795101","article-title":"Treating cocaine addiction with viruses","volume":"101","author":"Carrera","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.heliyon.2023.e19925_bib112","first-page":"2018","article-title":"Evaluation of the immune response of a candidate phage-based vaccine against rhipicephalus microplus (cattle tick). Pharmaceutics","volume":"vol. 13","author":"Gonz\u00e1lez-Mora","year":"2021"},{"issue":"7\u20138","key":"10.1016\/j.heliyon.2023.e19925_bib113","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s12010-011-9365-1","article-title":"Phage displayed HBV core antigen with immunogenic activity","volume":"165","author":"Bahadir","year":"2011","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e19925_bib114","first-page":"1833","volume":"5","author":"Ren","year":"1996","journal-title":"Phage display of intact domains at high copy number: a system based on SOC, the small outer capsid protein of bacteriophage T4"},{"key":"10.1016\/j.heliyon.2023.e19925_bib116","volume":"12","author":"Li","year":"2021","journal-title":"Bacteriophage T4 vaccine platform for next-generation influenza vaccine development"},{"issue":"37","key":"10.1016\/j.heliyon.2023.e19925_bib121","volume":"7","author":"Zhu","year":"2021","journal-title":"A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib122","first-page":"324","volume":"12","author":"Fougeroux","year":"2021","journal-title":"Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity"},{"key":"10.1016\/j.heliyon.2023.e19925_bib124","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/vaccines10010111","article-title":"Immunogenicity and protective capacity of a virus-like particle vaccine against Chlamydia trachomatis type 3 secretion system tip protein, CT584","volume":"10","author":"Webster","year":"2022","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e19925_bib125","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1021\/acsinfecdis.1c00585","article-title":"Virus-like particle display of Vibrio cholerae O-specific polysaccharide as a potential vaccine against cholera","volume":"8","author":"Rashidijahanabad","year":"2022","journal-title":"ACS Infect. Dis."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e19925_bib131","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/eji.200425322","article-title":"Cross\u2010presentation of phage particle antigen in MHC class II and endoplasmic reticulum marker\u2010positive compartments","volume":"35","author":"Wan","year":"2005","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib132","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10142","article-title":"Phage display as a tool for vaccine and immunotherapy development","volume":"5","author":"Hess","year":"2019","journal-title":"Bioengineering & translational medicine"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib133","article-title":"The overexpressed antigens in triple negative breast cancer and the application in immunotherapy","volume":"13","author":"Jirapongwattana","year":"2020","journal-title":"Genomics and Genetics"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e19925_bib134","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1470-2045(03)00982-3","article-title":"Cancer\/testis tumour-associated antigens: immunohistochemical detection with monoclonal antibodies","volume":"4","author":"Juretic","year":"2003","journal-title":"The lancet oncology"},{"key":"10.1016\/j.heliyon.2023.e19925_bib135","series-title":"Cancer\/testis Antigens: Potential Targets for Immunotherapy","first-page":"347","author":"Caballero","year":"2012"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e19925_bib136","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.4049\/jimmunol.180.6.3719","article-title":"The use of filamentous bacteriophage <em>fd<\/em> to deliver MAGE-A10 or MAGE-A3 HLA-A2-restricted peptides and to induce strong antitumor CTL responses","volume":"180","author":"Sartorius","year":"2008","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib137","first-page":"241","article-title":"Mucosal vaccination with phage-displayed tumour antigens identified through proteomics-based strategy inhibits the growth and metastasis of 4T1 breast adenocarcinoma","volume":"32","author":"Shadidi","year":"2008","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib138","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1038\/s41598-018-38371-z","article-title":"Lambda bacteriophage nanoparticles displaying GP2, a HER2\/neu derived peptide, induce prophylactic and therapeutic activities against TUBO tumor model in mice","volume":"9","author":"Razazan","year":"2019","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e19925_bib139","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1158\/2326-6066.CIR-18-0179","article-title":"Phage-based anti-HER2 vaccination can circumvent immune tolerance against breast cancer","volume":"6","author":"Bartolacci","year":"2018","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib140","first-page":"1","volume":"12","author":"Roehnisch","year":"2014","journal-title":"Phage idiotype vaccination: first phase I\/II clinical trial in patients with multiple myeloma"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e19925_bib141","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41541-019-0118-4","article-title":"Q\u00df Virus-like particle-based vaccine induces robust immunity and protects against tauopathy","volume":"4","author":"Maphis","year":"2019","journal-title":"npj Vaccines"},{"issue":"8","key":"10.1016\/j.heliyon.2023.e19925_bib142","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.202100014","article-title":"A single-dose, implant-based, trivalent virus-like particle vaccine against \u201ccholesterol checkpoint\u201d proteins","volume":"4","author":"Ortega-Rivera","year":"2021","journal-title":"Advanced Therapeutics"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023071335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023071335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T21:13:49Z","timestamp":1784927629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023071335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":142,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2405844023071335"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19925","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phage based vaccine: A novel strategy in prevention and treatment","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19925","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e19925"}}